Literature DB >> 24138392

Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.

Jianjian Zheng1, Cunzao Wu, Zhuo Lin, Yong Guo, Liang Shi, Peihong Dong, Zhongqiu Lu, Shenmeng Gao, Yi Liao, Bicheng Chen, Fujun Yu.   

Abstract

Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has been reported to play a role in the suppression of activated hepatic stellate cells (HSCs). Moreover, it has been demonstrated that hypermethylation of the PTEN promoter is responsible for the loss of PTEN expression during HSC activation. Methylation is now established as a fundamental regulator of gene transcription. MicroRNAs (miRNAs), which can control gene expression by binding to their target genes for degradation and/or translational repression, were found to be involved in liver fibrosis. However, the mechanism responsible for miRNA-mediated epigenetic regulation in liver fibrosis still remained unclear. In the present study, curcumin treatment significantly resulted in the inhibition of cell proliferation and an increase in the apoptosis rate through the up-regulation of PTEN associated with a decreased DNA methylation level. Only DNA methyltransferase 3b (DNMT3b) was reduced in vivo and in vitro after curcumin treatment. Further studies were performed aiming to confirm that the knockdown of DNMT3b enhanced the loss of PTEN methylation by curcumin. In addition, miR-29b was involved in the hypomethylation of PTEN by curcumin. MiR-29b not only was increased by curcumin in activated HSCs, but also was confirmed to target DNMT3b by luciferase activity assays. Curcumin-mediated PTEN up-regulation, DNMT3b down-regulation and PTEN hypomethylation were all attenuated by miR-29b inhibitor. Collectively, it is demonstrated that curcumin can up-regulate miR-29b expression, resulting in DNMT3b down-regulation in HSCs and epigenetically-regulated PTEN involved in the suppression of activated HSCs. These results indicate that miRNA-mediated epigenetic regulation may be a novel mechanism suppressing liver fibrosis.
© 2013 FEBS.

Entities:  

Keywords:  DNA methylation; DNA methyltransferase; hepatic stellate cells; microRNA-29b; phosphatase and tensin homologue deleted on chromosome 10

Mesh:

Substances:

Year:  2013        PMID: 24138392     DOI: 10.1111/febs.12574

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  45 in total

1.  Long non-coding RNAs and hepatocellular carcinoma.

Authors:  Fu-Jun Yu; Jian-Jian Zheng; Pei-Hong Dong; Xiao-Ming Fan
Journal:  Mol Clin Oncol       Date:  2014-09-25

Review 2.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

3.  The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes.

Authors:  Agata Page; Derek A Mann; Jelena Mann
Journal:  Curr Pathobiol Rep       Date:  2014-09-27

4.  Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.

Authors:  Jianjian Zheng; Cunzao Wu; Ziqiang Xu; Peng Xia; Peihong Dong; Bicheng Chen; Fujun Yu
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

Review 5.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

6.  MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Jing Cai; Kate Huang; Bicheng Chen; Guojun Li; Peihong Dong; Jianjian Zheng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.

Authors:  Fujun Yu; Zhe Jiang; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  J Mol Med (Berl)       Date:  2017-09-01       Impact factor: 4.599

8.  MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7.

Authors:  Fujun Yu; Yong Guo; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  Lab Invest       Date:  2015-04-27       Impact factor: 5.662

Review 9.  Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis.

Authors:  Kun-Yu Teng; Kalpana Ghoshal
Journal:  Gene Expr       Date:  2015

10.  Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA.

Authors:  Fujun Yu; Jianjian Zheng; Yuqing Mao; Peihong Dong; Zhongqiu Lu; Guojun Li; Chuanyong Guo; Zhanju Liu; Xiaoming Fan
Journal:  J Biol Chem       Date:  2015-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.